相关实验视频

Updated: May 12, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

作为一种治疗策略,COX-2抑制在黄金葡萄球菌骨髓炎中治疗骨质损失

Yuhui Chen^1,2, Chao Li^1,2, Jishan Jia^1,2

¹Division of Orthopedics and Traumatology, Department of Orthopedics, Nanfang Hospital, Southern Medical University, No. 1838 North of Guangzhou Avenue, Guangzhou, 510515, Guangdong, China.

Molecular medicine (Cambridge, Mass.)

|May 7, 2025

概括

黄金葡萄球菌感染会通过增加骨质细胞和减少骨质细胞而导致骨质损失,这种损失由COX-2介导. 抑制COX-2使用赛莱科克西布挽救了骨质损失,这表明骨髓炎的治疗点.

科学领域:

免疫学免疫学免疫学
整形外科整形外科整形外科
药理学药理学是指药理学的学科.

背景情况:

黄金葡萄球菌 (S. aureus) 骨髓炎导致显著的骨质损失,在骨科治疗中是一个挑战.
导致慢性黄金色杆菌感染的系统性骨质疏松症的确切机制尚不清楚.

研究的目的:

为了研究由S. aureus感染引起的全身性骨损失的机制.
探索循环氧化酶-2 (COX-2) 在S. aureus引起的骨损失中的作用及其治疗潜力.

主要方法:

用γ辐射杀死黄金菌 (IKSA) 模拟感染并诱导小鼠系统性骨损失.
对骨髓细胞的转录分析确定了上调的COX-2.
评估了COX-2抑制剂赛莱科西布对骨质损失和炎症基因表达的影响.

主要成果:

通过增加骨质细胞和减少骨质细胞,IKSA治疗导致骨质损失.
在骨髓免疫细胞中,COX-2的调控显著上升,包括骨髓衍生抑制细胞 (MDSC),中性粒细胞和巨细胞.
切莱科克西布治疗逆转了骨损失,并减少了这些免疫细胞中的炎症基因表达.

结论:

通过调节免疫细胞的反应,COX-2在调节S. aureus诱导的骨损失方面发挥着至关重要的作用.
在实验和人类黄金色杆菌骨髓炎中都观察到COX-2表达的增加.
抑制COX-2代表了一种有前途的治疗策略,用于对抗与S. aureus骨髓炎相关的骨质损失.

更多相关视频

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

相关概念视频

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...

Peptic Ulcer Disease IV: Management

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...